Aerpio pharmaceuticals, inc. (ARPO)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Assets
Current assets:
Cash and cash equivalents

34,584

38,524

43,389

48,157

53,422

62,614

68,807

68,783

13,763

20,264

24,828

28,847

35,139

1,609

7

20

13

5,144

6

10

23

5

17

4

5

6

10

18

2

4

5

9

23

4

6

9

26

Short-term investments

-

-

-

-

-

-

-

-

-

-

50

50

50

50

-

-

-

50

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

-

-

-

-

-

-

-

-

-

-

39

4

32

4

-

-

-

118

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid research and development contracts

228

311

538

368

340

754

337

428

388

313

323

311

297

353

-

-

-

266

-

-

-

-

0

0

0

2

4

0

1

3

5

6

0

2

4

6

2

Other current assets

578

734

876

264

536

615

895

213

457

322

621

431

602

209

-

-

-

386

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current assets

35,392

39,570

44,804

48,789

54,299

63,984

70,039

69,425

14,610

20,899

25,863

29,644

36,121

2,226

-

-

-

5,965

-

-

-

-

-

-

-

-

-

-

3

-

11

15

24

6

10

15

29

Furniture and equipment, net

149

164

281

297

198

98

101

92

103

107

116

129

138

149

-

-

-

105

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease right-of-use assets, net

138

162

424

472

517

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposits

20

40

40

40

40

40

20

20

20

20

20

20

20

20

-

-

-

20

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total assets

35,700

39,936

45,551

49,600

55,056

64,123

70,161

69,538

14,734

21,027

26,001

29,794

36,280

2,396

7

20

13

6,092

6

10

23

5

17

4

6

8

14

18

-

8

-

-

-

-

-

-

-

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued expenses

2,547

3,231

3,403

3,402

3,734

5,456

3,644

2,965

3,622

3,592

2,586

1,856

2,970

2,470

-

-

-

2,159

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of operating lease liability

106

102

197

193

189

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

18,666

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

12,386

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

10

8

-

2

1

10

2

10

8

0

0

0

0

6

1

0

0

3

2

2

2

2

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

39

37

34

-

30

28

25

24

22

20

18

17

15

13

12

11

10

8

7

6

-

-

2

Accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

3

3

-

3

3

3

8

3

2

7

5

3

2

1

5

1

1

1

5

7

6

5

Notes payable, stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

170

170

160

-

145

145

145

125

125

110

110

110

110

110

85

85

85

85

85

60

60

60

60

Total current liabilities

2,654

3,334

3,601

3,595

3,923

5,456

3,644

21,632

3,622

3,592

2,586

1,856

2,970

14,857

215

220

206

2,159

180

178

184

160

161

141

136

133

129

126

105

103

97

95

97

74

69

68

70

Operating lease liability, net of current portion

39

67

236

288

337

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

2,693

3,401

3,837

3,883

4,261

5,456

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Commitments and contingencies (Note 9)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Redeemable convertible preferred stock (all classes)

-

-

-

-

-

-

-

-

-

-

-

-

-

73,757

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Redeemable convertible preferred stock (all classes)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

70,487

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.0001 par value per share; 300,000,000 shares authorized and 40,588,004 shares issued and outstanding at March 31, 2020 and December 31, 2019.

4

4

4

4

4

4

4

3

2

2

2

2

2

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Additional paid-in capital

179,156

178,766

179,499

178,853

178,249

177,621

176,953

169,880

127,097

125,995

125,740

125,612

125,465

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49

-

49

49

49

49

49

49

49

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49

49

49

-

49

49

49

49

49

49

49

49

49

49

-

49

-

-

-

-

-

-

-

Accumulated deficit

-146,154

-142,235

-137,789

-133,141

-127,457

-118,959

-110,440

-121,978

-115,988

-108,562

-102,327

-97,678

-92,157

-86,218

-257

-250

-242

-66,554

-224

-218

-210

-205

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deficit accumulated during the development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

193

186

180

174

164

158

151

145

135

129

123

118

109

102

90

Total stockholders’ equity

33,006

36,535

41,714

45,716

50,795

58,666

66,517

47,906

11,111

17,435

23,415

27,937

33,310

-86,218

-207

-200

-192

-66,554

-174

-168

-160

-155

-143

-136

-130

-124

-114

-108

-101

-95

-85

-79

-73

-68

-59

-52

-40

Total liabilities and stockholders’ equity

35,700

39,936

45,551

49,600

55,056

64,123

70,161

69,538

14,734

21,027

26,001

29,794

36,280

2,396

7

20

13

6,092

6

10

23

5

17

4

6

8

14

18

3

8

11

15

24

6

10

15

29